Chief Medical Officer · LENZ Therapeutics, Inc. · LENZ Therapeutics, Inc. — Stock Option (right to buy)
Side
A
Value
—
Shares
84.2K
Price
—
Executed
Jan 2, 2026
Disclosed
Jan 6, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Jan 2 executedJan 6, 2026 disclosed
LENZ · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
LENZ Therapeutics, Inc. — Stock Option (right to buy)
Ticker
LENZ
Shares
84.2K
Price per share
$0
Execution date (reported)
Jan 2, 2026
Owned after transaction
84.2K shares
Days from execution to publication
4
What this establishes
Odrich Marc filed this Form 4 reporting a grant or award of LENZ on Jan 2, 2026. It became public on Jan 6, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Medical Officer
Odrich Marccik:0002015900
Issuer
LENZ Therapeutics, Inc.cik:0001815776
Revision history · 0
No field has changed since this record was first ingested.
